<--- Back to Details
First PageDocument Content
Pershing Square Capital Management / Bill Ackman / Lawsuit / Tender offer / Williams Act / Investment / Finance / Financial economics / Companies listed on the New York Stock Exchange / Valeant Pharmaceuticals / Allergan
Date: 2014-08-01 11:52:53
Pershing Square Capital Management
Bill Ackman
Lawsuit
Tender offer
Williams Act
Investment
Finance
Financial economics
Companies listed on the New York Stock Exchange
Valeant Pharmaceuticals
Allergan

Microsoft Word - 1795793_17.doc

Add to Reading List

Source URL: go.bloomberg.com

Download Document from Source Website

File Size: 200,30 KB

Share Document on Facebook

Similar Documents

      Valeant Pharmaceuticals International, Inc.  400 Somerset Corporate Boulevard, Bridgewater, NJ 08807 

DocID: 1rD6j - View Document

Business / Economy / Health care / Gilead Sciences / Specialty drugs / Pharmaceuticals policy / Tenofovir alafenamide / Valeant Pharmaceuticals / Tenofovir disoproxil / Rilpivirine / Pharmaceutical industry in China / AstraZeneca

March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

DocID: 1rdax - View Document

Business / Economy / Biotechnology / CAC 40 / Sanofi / AstraZeneca / Novartis / Takeda Pharmaceutical Company / Valeant Pharmaceuticals / Pharmaceutical industry in China / Bausch & Lomb / Pharmaceutical industry in India

February 5, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum.  Sponsored By:

DocID: 1r6rO - View Document

S&P/TSX 60 Index / S&P/TSX Composite Index / Valeant Pharmaceuticals / Arbutin / Skin whitening / TSX / Sirona / Hydroquinone / SBM / Economy of Canada / Economy / Religion

Investor Presentation Jan 31, 2016 TM TSX-V: SBM

DocID: 1r4gv - View Document

Economy / Finance / Money / Investment / Financial ratios / Mathematical finance / Stock market / Valuation / Rate of return / Ruane /  Cunniff & Goldfarb / Valeant Pharmaceuticals / Earnings growth

Sequoia Fund, Inc. ANNUAL REPORT DECEMBER 31, 2013

DocID: 1qfcU - View Document